Nuzenio

Dsgn

Dsgn news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 9 publisher sources 100/100 entity strength

Latest news

DSGN Aug 2026 3.000 put (DSGN260821P00003000) interactive stock chart - Yahoo Finance SingaporeYahoo Finance Singapore · Sun, 09 Aug 2026 12:26:46 GMT Design Therapeutics Inc (DSGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 21:40:47 GMT DSGN Aug 2026 12.000 call (DSGN260821C00012000) stock historical prices and data - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 20:13:07 GMT Renaissance Technologies LLC Buys 121,100 Shares of Design Therapeutics, Inc. $DSGN - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:44:46 GMT Design Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:59:52 GMT Craig-Hallum Maintains Design Therapeutics(DSGN.US) With Buy Rating, Maintains Target Price $22 - MoomooMoomoo · Tue, 04 Aug 2026 15:33:00 GMT Design Therapeutics Q2 Net Loss Narrows - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:43:50 GMT Design Therapeutics, Inc. 2Q 2026: Net loss $(20,165)K, EPS $(0.32) — 10-Q Summary - TradingViewTradingView · Mon, 03 Aug 2026 12:11:01 GMT

Timeline

Sun, 09 Aug 2026 12:26:46 GMTDSGN Aug 2026 3.000 put (DSGN260821P00003000) interactive stock chart - Yahoo Finance Singapore

Fri, 07 Aug 2026 21:40:47 GMTDesign Therapeutics Inc (DSGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Fri, 07 Aug 2026 20:13:07 GMTDSGN Aug 2026 12.000 call (DSGN260821C00012000) stock historical prices and data - Yahoo Finance Australia

Fri, 07 Aug 2026 08:44:46 GMTRenaissance Technologies LLC Buys 121,100 Shares of Design Therapeutics, Inc. $DSGN - MarketBeat

Wed, 05 Aug 2026 11:59:52 GMTDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Tue, 04 Aug 2026 15:33:00 GMTCraig-Hallum Maintains Design Therapeutics(DSGN.US) With Buy Rating, Maintains Target Price $22 - Moomoo

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Inc8 live mentions Design Therapeutics Inc6 live mentions Design Therapeutics6 live mentions DSGN Aug4 live mentions Therapeutics4 live mentions The Descartes Systems4 live mentions Group4 live mentions Earnings Report4 live mentions Results4 live mentions Call4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Dsgn.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.